Cartesian Therapeutics, Inc. 10-K

Filed 2025-03-13 · Original on SEC.gov

Attached exhibits

EX-4.1 · Indenture or security terms EX-4.12 · Indenture or security terms EX-10.3 · Material contract EX-10.5 · Material contract EX-19.1 · Insider trading policy EX-21.1 · Subsidiaries EX-23.1 · Auditor consent

Item 8. Financial Statements and Supplementary Data

Item 8. Financial Statements and Supplementary Data 
 The consolidated financial statements together with the report of our independent registered public company accounting firm, required to be filed pursuant to this Item 8 are appended to this Annual Report. An index of those consolidated financial statements is found in Item 15. 
 
 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 
 None.

Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.